Bill > AB1037

This bill makes several significant changes to California's laws regarding substance use disorder prevention, treatment, and recovery. The bill expands authorizations for opioid antagonist (such as naloxone) distribution and administration, removing the requirement for training and broadening who can possess and distribute these life-saving medications. It requires the State Department of Health Care Services to offer a combined application for alcohol and drug recovery facilities by 2027 and prohibits facilities from requiring patients to be abstinent to be admitted or continue treatment. The bill redefines "drug- or alcohol-related program" to focus on assisting persons with substance use disorders and requires such programs to be consistent with evidence-based clinical practices to receive state funding. Additionally, the bill modifies regulations for residential treatment facilities, emphasizing maintaining treatment connections even after a relapse and allowing for more flexible admission criteria. The legislation also updates provisions related to drug program fees, prevention programs, and incidental medical services in recovery facilities, with a overall approach that views substance use disorder as a health issue requiring compassionate, evidence-based treatment approaches.

Budget and Finance, Health and Social Services, Justice

https://leginfo.legislature.ca.gov/faces/billStatusClient.xhtml?bill_id=202520260AB1037